Displaying 2 results for

Many pharmaceutical companies urgently began developing a COVID-19 vaccine earlier this year to reduce the spread of the virus as the threat of a pandemic loomed. Fast forward several months and millions of COVID-19 cases later, states and territories are preparing to distribute a potential vaccine with preliminary plans for distributing a COVID-19 vaccine due to the CDC in October.

The COVID-19 pandemic has underscored the consequences of decades of underfunding. To ensure we are better prepared for future pandemics and biological threats, we must consider the long-term investments required to bolster our public health infrastructure and workforce.